{"id":568,"kind":"story","title":"Insights for AI Startups' Global Leap","url":"https://www.venturesquare.net/1097147/","host":"venturesquare.net","by":"mrlatte","score":1,"comments":0,"time":"2026-07-09T03:04:41.000Z","origin":"archive","language":{"source":"ko","reading":"en","translated":true},"summary":["Sixsense and J&P Medi are accelerating their overseas expansion by being selected for Y Combinator's Summer 2026 batch and the Unicorn Bridge program.","While the schedules for batches and support programs move quickly, the pace at which manufacturing sites and clinical trials are adopted do not move at the same rhythm.","The variable that can advance the timetable is the speed of collecting data and proving efficiency on site rather than just prior information.","Participating in the programs should be viewed not as the completion of overseas expansion but as the start of validation."],"discussion":"https://startupxo.com/en/568/","markdown":"https://startupxo.com/en/568.md","api":"https://startupxo.com/api/v1/item.json?id=568&lang=en","text":null,"edited":null,"sources":[],"thread":[]}